Please sign in to follow a disease.

EGFR L858R

Clinical trials for EGFR L858R explained in plain language.

Never miss a new study

Get alerted when new EGFR L858R trials appear

Sign up with your email to follow new studies for EGFR L858R, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Can a smart drug outperform chemo for Hard-to-Treat lung cancer?

Disease control Ongoing

This phase 3 trial compares an experimental drug called patritumab deruxtecan with standard platinum-based chemotherapy in people with a specific type of non-small cell lung cancer that has an EGFR mutation and has progressed after EGFR-targeted therapy. The drug is designed to d…

Matched conditions: EGFR L858R

Phase 3 • Sponsor: Daiichi Sankyo • Aim: Disease control

Last updated Aug 29, 2026 00:00 UTC

EGFR L858R

Get alerted when new EGFR L858R trials appear

Can a smart drug outperform chemo for Hard-to-Treat lung cancer?